Myocardial indium-111 antimyosin uptake after uncomplicated coronary artery bypass surgery

Ettore Astorri, Giovanni Andrea Contini, Paolo Fiorina, Gilberto Gavaruzzi, Francesco Fesani

Research output: Contribution to journalArticle

Abstract

The prevalence of myocardial damage after coronary artery bypass grafting is related to the criteria of its evaluation. Indium-111 monoclonal antimyosin antibody scintigraphy has been shown to be highly sensitive and specific for even small areas of myocardial necrosis or injury like those of myocarditis or transplant rejection. Our purpose was to evaluate, by using this method, myocardial damage after uncomplicated coronary artery bypass grafting. Uptake of this radio tracer was evaluated after coronary artery bypass grafting in 14 informed and consenting consecutive patients without previous myocardial infarction, with no post-surgical complications and a favorable postoperative course, following coronary artery bypass grafting for stable angina pectoris. Monoclonal antimyosin antibody indium-111 74 MBq (Myoscint Centocor) was injected on the third postoperative day; planar images in the anterior, left anterior oblique 45° and 70° projections were obtained 24 and 48 h later and analyzed for myocardial uptake. Indium-111 antimyosin uptake was present in 10 out of 14 patients (71.4%); it was diffuse in 6 and localized in 4. The ratio of the maximal counts in the myocardium to the counts in the adjacent lung background was measured and found elevated: 1.94 ± 0.23, higher than the normal values reported in the literature. Indium-111 antimyosin uptake was clear in a group of patients after uncomplicated coronary artery bypass grafting, No correlation was observed between indium-111 antimyosin uptake or heart to lung ratio and creatine kinase, creatine kinase isoenzyme MB, glutamic oxalacetic transferase levels, duration of cardiopulmonary bypass or aortic cross-clamp time, while elevated serum β myosin heavy chain fragments (IRMA Pasteur) were observed (1378 ± 238 μU/l). This study suggests that some degree of myocardial damage, though silent, is common after coronary artery bypass grafting.

Original languageEnglish
Pages (from-to)239-244
Number of pages6
JournalInternational Journal of Cardiology
Volume55
Issue number3
DOIs
Publication statusPublished - Aug 1996

Fingerprint

Coronary Artery Bypass
Monoclonal Antibodies
MB Form Creatine Kinase
Lung
Stable Angina
Myosin Heavy Chains
Myocarditis
Graft Rejection
Creatine Kinase
Transferases
Cardiopulmonary Bypass
Radio
Radionuclide Imaging
Isoenzymes
imciromab pentetate
Myocardium
Reference Values
Necrosis
Myocardial Infarction
Wounds and Injuries

Keywords

  • Coronary artery bypass graft
  • Indium-111 antimyosin antibody
  • Myocardial damage

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Myocardial indium-111 antimyosin uptake after uncomplicated coronary artery bypass surgery. / Astorri, Ettore; Contini, Giovanni Andrea; Fiorina, Paolo; Gavaruzzi, Gilberto; Fesani, Francesco.

In: International Journal of Cardiology, Vol. 55, No. 3, 08.1996, p. 239-244.

Research output: Contribution to journalArticle

Astorri, Ettore ; Contini, Giovanni Andrea ; Fiorina, Paolo ; Gavaruzzi, Gilberto ; Fesani, Francesco. / Myocardial indium-111 antimyosin uptake after uncomplicated coronary artery bypass surgery. In: International Journal of Cardiology. 1996 ; Vol. 55, No. 3. pp. 239-244.
@article{dbfec35297ee43e0aef9b8243cc88e9c,
title = "Myocardial indium-111 antimyosin uptake after uncomplicated coronary artery bypass surgery",
abstract = "The prevalence of myocardial damage after coronary artery bypass grafting is related to the criteria of its evaluation. Indium-111 monoclonal antimyosin antibody scintigraphy has been shown to be highly sensitive and specific for even small areas of myocardial necrosis or injury like those of myocarditis or transplant rejection. Our purpose was to evaluate, by using this method, myocardial damage after uncomplicated coronary artery bypass grafting. Uptake of this radio tracer was evaluated after coronary artery bypass grafting in 14 informed and consenting consecutive patients without previous myocardial infarction, with no post-surgical complications and a favorable postoperative course, following coronary artery bypass grafting for stable angina pectoris. Monoclonal antimyosin antibody indium-111 74 MBq (Myoscint Centocor) was injected on the third postoperative day; planar images in the anterior, left anterior oblique 45° and 70° projections were obtained 24 and 48 h later and analyzed for myocardial uptake. Indium-111 antimyosin uptake was present in 10 out of 14 patients (71.4{\%}); it was diffuse in 6 and localized in 4. The ratio of the maximal counts in the myocardium to the counts in the adjacent lung background was measured and found elevated: 1.94 ± 0.23, higher than the normal values reported in the literature. Indium-111 antimyosin uptake was clear in a group of patients after uncomplicated coronary artery bypass grafting, No correlation was observed between indium-111 antimyosin uptake or heart to lung ratio and creatine kinase, creatine kinase isoenzyme MB, glutamic oxalacetic transferase levels, duration of cardiopulmonary bypass or aortic cross-clamp time, while elevated serum β myosin heavy chain fragments (IRMA Pasteur) were observed (1378 ± 238 μU/l). This study suggests that some degree of myocardial damage, though silent, is common after coronary artery bypass grafting.",
keywords = "Coronary artery bypass graft, Indium-111 antimyosin antibody, Myocardial damage",
author = "Ettore Astorri and Contini, {Giovanni Andrea} and Paolo Fiorina and Gilberto Gavaruzzi and Francesco Fesani",
year = "1996",
month = "8",
doi = "10.1016/S0167-5273(96)02691-5",
language = "English",
volume = "55",
pages = "239--244",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Myocardial indium-111 antimyosin uptake after uncomplicated coronary artery bypass surgery

AU - Astorri, Ettore

AU - Contini, Giovanni Andrea

AU - Fiorina, Paolo

AU - Gavaruzzi, Gilberto

AU - Fesani, Francesco

PY - 1996/8

Y1 - 1996/8

N2 - The prevalence of myocardial damage after coronary artery bypass grafting is related to the criteria of its evaluation. Indium-111 monoclonal antimyosin antibody scintigraphy has been shown to be highly sensitive and specific for even small areas of myocardial necrosis or injury like those of myocarditis or transplant rejection. Our purpose was to evaluate, by using this method, myocardial damage after uncomplicated coronary artery bypass grafting. Uptake of this radio tracer was evaluated after coronary artery bypass grafting in 14 informed and consenting consecutive patients without previous myocardial infarction, with no post-surgical complications and a favorable postoperative course, following coronary artery bypass grafting for stable angina pectoris. Monoclonal antimyosin antibody indium-111 74 MBq (Myoscint Centocor) was injected on the third postoperative day; planar images in the anterior, left anterior oblique 45° and 70° projections were obtained 24 and 48 h later and analyzed for myocardial uptake. Indium-111 antimyosin uptake was present in 10 out of 14 patients (71.4%); it was diffuse in 6 and localized in 4. The ratio of the maximal counts in the myocardium to the counts in the adjacent lung background was measured and found elevated: 1.94 ± 0.23, higher than the normal values reported in the literature. Indium-111 antimyosin uptake was clear in a group of patients after uncomplicated coronary artery bypass grafting, No correlation was observed between indium-111 antimyosin uptake or heart to lung ratio and creatine kinase, creatine kinase isoenzyme MB, glutamic oxalacetic transferase levels, duration of cardiopulmonary bypass or aortic cross-clamp time, while elevated serum β myosin heavy chain fragments (IRMA Pasteur) were observed (1378 ± 238 μU/l). This study suggests that some degree of myocardial damage, though silent, is common after coronary artery bypass grafting.

AB - The prevalence of myocardial damage after coronary artery bypass grafting is related to the criteria of its evaluation. Indium-111 monoclonal antimyosin antibody scintigraphy has been shown to be highly sensitive and specific for even small areas of myocardial necrosis or injury like those of myocarditis or transplant rejection. Our purpose was to evaluate, by using this method, myocardial damage after uncomplicated coronary artery bypass grafting. Uptake of this radio tracer was evaluated after coronary artery bypass grafting in 14 informed and consenting consecutive patients without previous myocardial infarction, with no post-surgical complications and a favorable postoperative course, following coronary artery bypass grafting for stable angina pectoris. Monoclonal antimyosin antibody indium-111 74 MBq (Myoscint Centocor) was injected on the third postoperative day; planar images in the anterior, left anterior oblique 45° and 70° projections were obtained 24 and 48 h later and analyzed for myocardial uptake. Indium-111 antimyosin uptake was present in 10 out of 14 patients (71.4%); it was diffuse in 6 and localized in 4. The ratio of the maximal counts in the myocardium to the counts in the adjacent lung background was measured and found elevated: 1.94 ± 0.23, higher than the normal values reported in the literature. Indium-111 antimyosin uptake was clear in a group of patients after uncomplicated coronary artery bypass grafting, No correlation was observed between indium-111 antimyosin uptake or heart to lung ratio and creatine kinase, creatine kinase isoenzyme MB, glutamic oxalacetic transferase levels, duration of cardiopulmonary bypass or aortic cross-clamp time, while elevated serum β myosin heavy chain fragments (IRMA Pasteur) were observed (1378 ± 238 μU/l). This study suggests that some degree of myocardial damage, though silent, is common after coronary artery bypass grafting.

KW - Coronary artery bypass graft

KW - Indium-111 antimyosin antibody

KW - Myocardial damage

UR - http://www.scopus.com/inward/record.url?scp=0030220344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030220344&partnerID=8YFLogxK

U2 - 10.1016/S0167-5273(96)02691-5

DO - 10.1016/S0167-5273(96)02691-5

M3 - Article

C2 - 8877423

AN - SCOPUS:0030220344

VL - 55

SP - 239

EP - 244

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

IS - 3

ER -